Genelux Corp Stock Ownership - Who owns Genelux?

Insider buying vs selling

Have Genelux Corp insiders been buying or selling?
Sean RyderGeneral Counsel2024-06-245,496$2.12
Caroline JewettHead of Quality2024-06-244,961$2.12
Yong YuVP Clinical Trial Operations2024-06-246,849$2.12
Aladar Szalay10% Owner2024-05-1517,094$3.66
Aladar Szalay10% Owner2024-05-1415,426$3.58
Aladar Szalay10% Owner2024-05-133,446$3.62
Aladar Szalay10% Owner2024-05-0813,919$3.82
Aladar Szalay10% Owner2024-05-076,025$3.67
Aladar Szalay10% Owner2024-05-0133,061$3.30
Aladar Szalay10% Owner2024-04-3020,535$3.12

1 of 10

GNLX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GNLX insiders and whales buy or sell their stock.

GNLX Shareholders

What type of owners hold Genelux Corp stock?
Blackrock Inc4.56%1,231,803$2.72MInstitution
Woodward Diversified Capital LLC4.02%1,085,957$2.40MInstitution
Vanguard Group Inc3.79%1,023,030$2.26MInstitution
Aladar Szalay2.06%555,000$1.23MInsider
John Thomas1.73%465,960$1.03MInsider
Geode Capital Management LLC1.57%424,265$937.63kInstitution
State Street Corp1.46%395,015$872.98kInstitution
Millennium Management LLC0.97%261,799$578.58kInstitution
Thomas Zindrick0.80%214,651$474.38kInsider
Northern Trust Corp0.60%162,485$359.09kInstitution

1 of 3

GNLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GNLX22.29%6.28%Net SellingNet Selling
ALRN4.75%95.25%Net SellingNet Selling
IMMX19.27%32.84%Net BuyingNet Buying
MURA71.45%2.58%Net SellingNet Selling

Genelux Stock Ownership FAQ

Who owns Genelux?

Genelux (NASDAQ: GNLX) is owned by 22.29% institutional shareholders, 6.28% Genelux insiders, and 71.43% retail investors. Aladar Szalay is the largest individual Genelux shareholder, owning 555,000.00 shares representing 2.06% of the company. Aladar Szalay's Genelux shares are currently valued at $1.22M.

If you're new to stock investing, here's how to buy Genelux stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.